Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cardiovascular Syst (CSII)

Cardiovascular Syst (CSII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 843,960
  • Shares Outstanding, K 42,198
  • Annual Sales, $ 236,220 K
  • Annual Income, $ -36,930 K
  • 60-Month Beta 0.74
  • Price/Sales 3.57
  • Price/Cash Flow N/A
  • Price/Book 3.50
Trade CSII with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.97
  • Most Recent Earnings $-0.20 on 02/08/23
  • Latest Earnings Date 05/03/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate -0.15
  • Number of Estimates 4
  • High Estimate -0.12
  • Low Estimate -0.19
  • Prior Year -0.25
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.84 +0.81%
on 03/30/23
20.00 unch
on 04/27/23
+0.14 (+0.70%)
since 03/27/23
3-Month
13.00 +53.85%
on 02/08/23
20.00 unch
on 04/27/23
+6.62 (+49.48%)
since 01/27/23
52-Week
12.26 +63.20%
on 10/11/22
20.57 -2.77%
on 05/03/22
+0.03 (+0.15%)
since 04/27/22

Most Recent Stories

More News
Cytek Biosciences Set to Join S&P SmallCap 600

/PRNewswire/ -- Cytek Biosciences Inc (NASD:CTKB) will replace Cardiovascular Systems Inc. (NASD:CSII) in the S&P SmallCap 600 effective prior to the opening...

SPGI : 415.31 (+0.78%)
CTKB : 5.84 (-1.35%)
CSII : 20.00 (+0.15%)
ABT : 105.55 (-0.33%)
SHAREHOLDER UPDATE: Halper Sadeh LLC Investigates CSII, ANGN, OSH, NUVA

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CSII : 20.00 (+0.15%)
ANGN : 10.0000 (+2.04%)
OSH : 39.00 (+0.08%)
NUVA : 39.75 (-2.24%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSII, NUVA, OSH, MAXR

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CSII : 20.00 (+0.15%)
NUVA : 39.75 (-2.24%)
OSH : 39.00 (+0.08%)
MAXR : 52.99 (+0.02%)
Cardiovascular Systems (CSII) Finishes ECLIPSE Trial Enrollment

Cardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calcified coronary arteries.

CSII : 20.00 (+0.15%)
PODD : 168.77 (+1.51%)
LNTH : 63.66 (+3.55%)
AVNS : 18.73 (+0.11%)
Cardiovascular Systems, Inc. Completes Enrollment of ECLIPSE Clinical Trial

Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease,...

CSII : 20.00 (+0.15%)
CARDIOVASCULAR SYSTEMS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Cardiovascular Systems, Inc. - CSII

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Cardiovascular Systems, Inc. (“CSI”) (NasdaqGS:...

CSII : 20.00 (+0.15%)
ABT : 105.55 (-0.33%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSII, NUVA, SUMO, OSH

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

CSII : 20.00 (+0.15%)
NUVA : 39.75 (-2.24%)
SUMO : 12.04 (-0.08%)
OSH : 39.00 (+0.08%)
Why Is NuVasive (NUVA) Down 15.9% Since Last Earnings Report?

NuVasive (NUVA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NUVA : 39.75 (-2.24%)
CSII : 20.00 (+0.15%)
Why Is Medtronic (MDT) Down 6.1% Since Last Earnings Report?

Medtronic (MDT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MDT : 78.98 (-0.13%)
CSII : 20.00 (+0.15%)
Cardiovascular Systems (CSII) Ails From Soft Volume, Macro Woes

Tough competition and consistent net loss continue to pose threats to Cardiovascular Systems (CSII).

HAE : 85.89 (+1.19%)
CSII : 20.00 (+0.15%)
KERN : 6.2720 (+36.94%)
TRSSF : 1.7200 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Cardiovascular Systems, Inc. is a medical device manufacturer that develops and commercializes innovative solutions to treat patients suffering from peripheral and coronary arterial diseases, including those with arterial calcium. The foundation of the company's business is catheter-based platforms,...

See More

Key Turning Points

3rd Resistance Point 20.03
2nd Resistance Point 20.01
1st Resistance Point 20.01
Last Price 20.00
1st Support Level 19.99
2nd Support Level 19.97
3rd Support Level 19.97

See More

52-Week High 20.57
Last Price 20.00
Fibonacci 61.8% 17.39
Fibonacci 50% 16.41
Fibonacci 38.2% 15.43
52-Week Low 12.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar